SEC Form 3 · accession 0001179110-18-003272
ABIOMED INC · ABMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ian McLeod
Officer — VP, Corporate Controller
Period of report
Feb 28, 2018
Accepted (ET)
Mar 2, 2018 · 4:21 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000815094
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $.01 par value | holding | — | — | — | 7,079 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1,F3 | $66.25 | holding | — | — | — | May 13, 2016 | May 13, 2025 | Common Stock | 1,667 | — | D |
| Stock Option (Right to Buy)F2,F3 | $99.62 | holding | — | — | — | May 24, 2017 | May 24, 2016 | Common Stock | 1,334 | — | D |
| Stock Option (Right to Buy)F2,F3 | $134.51 | holding | — | — | — | May 15, 2018 | May 15, 2027 | Common Stock | 3,000 | — | D |
Explanation of responses
- F1Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 3, under the ABIOMED, Inc. 2008 Stock Incentive Plan.
- F2Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 3, under the ABIOMED, Inc. 2015 Omnibus Incentive Plan.
- F3These options become exercisable in annual 33-1/3% increments, commencing on the date shown in Table II, Column 2